Created by the World Health Organization (WHO) in 1995, each year World Health Day draws attention to a major global health concern. This year focuses on the serious threat of vector-borne illnesses with a “Small bite, big threat” campaign. To learn more about Lilly’s part in this global effort, please check out my American colleague’s post.
Here in Canada, we have an additional exciting event to highlight. Today, the Canadian Diabetes Association (CDA) unveiled the first-ever Diabetes Charter for Canada. Through extensive research and consultation with more than 200 people across Canada, the CDA developed a charter that puts forth a vision for Canadians with diabetes. It debuts at a particularly crucial time, as diabetes becomes more prevalent throughout our country. Nine million Canadians live with diabetes or pre-diabetes and, even more astonishing, doctors newly diagnose 20 people every hour of every day.
Over 90 years ago, Lilly became the first company to make insulin commercially available. We’ve come a long way since then, but the fight continues and our heritage keeps us closely tied to this fight. We remain committed to beating diabetes and our $320 million investments in new insulin manufacturing since November 2012 tells just part of this story.
More progress can and will happen through collaboration. Partnering with groundbreaking organizations like CDA helps take us all closer to a cure. This new Charter will help Canadians from coast to coast by creating movement towards a common vision for diabetes prevention, management, support and care.
We invite you to join us in participating in this important nationwide initiative by signing the Diabetes Charter for Canada online, today!